Table 8.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 2000 to 2009

Recipients with Kidney-Pancreas Transplants

	Transplant Year
	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009
Functioning Graft at Discharge	888	861	881	847	864	884	905	842	820	836
With Immunosuppression Info	886	861	881	844	851	879	891	833	817	821
CyA	0.1%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.1%
Tac	0.9%	1.4%	2.3%	1.1%	3.4%	0.8%	1.1%	1.1%	0.9%	1.1%
--- + MMF/MPA	0.0%	0.0%	0.0%	1.1%	2.0%	1.0%	0.2%	0.0%	0.1%	0.2%
CyA + MMF/MPA	0.0%	0.0%	0.0%	0.4%	0.2%	0.7%	0.1%	0.4%	0.5%	0.0%
Tac + MMF/MPA	1.1%	0.6%	1.1%	4.0%	6.7%	14.8%	21.3%	24.1%	21.7%	23.4%
Tac + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%	0.4%
--- + Siro/Evero	0.0%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.2%	0.1%
CyA + Siro/Evero	0.0%	0.0%	0.0%	1.3%	2.8%	2.8%	3.1%	2.3%	3.2%	1.8%
Tac + Siro/Evero	0.3%	1.6%	4.5%	3.6%	3.8%	6.1%	2.2%	1.3%	0.1%	0.9%
--- + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	2.4%	4.5%	0.2%	0.2%	0.2%	0.0%	0.0%
CyA + MMF/MPA + Siro/Evero	0.0%	0.0%	0.1%	0.0%	0.0%	0.3%	0.2%	0.0%	0.0%	0.0%
Tac + MMF/MPA + Siro/Evero	0.0%	1.5%	1.8%	2.1%	0.9%	1.8%	4.6%	4.4%	2.6%	1.8%
--- + Steroids	1.1%	0.1%	0.0%	1.7%	0.8%	2.2%	0.0%	0.1%	0.0%	0.6%
CyA + Steroids	0.5%	0.3%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Tac + Steroids	1.7%	2.3%	1.8%	2.5%	1.5%	2.5%	3.0%	1.3%	2.3%	2.7%
--- + MMF/MPA + Steroids	0.1%	0.8%	0.5%	0.8%	1.3%	0.5%	0.7%	0.4%	0.4%	1.0%
CyA + MMF/MPA + Steroids	12.2%	8.5%	6.9%	5.0%	1.4%	1.8%	1.6%	1.2%	0.5%	1.1%
Tac + MMF/MPA + Steroids	64.6%	61.7%	66.3%	62.4%	64.7%	59.8%	53.6%	59.5%	65.0%	62.6%
--- + OtherAntimet + Steroids	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
CyA + OtherAntimet + Steroids	0.3%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%
Tac + OtherAntimet + Steroids	1.0%	0.1%	0.5%	0.7%	0.2%	0.0%	0.6%	0.4%	0.0%	0.2%
--- + Siro/Evero + Steroids	0.0%	0.0%	0.2%	0.2%	0.4%	0.0%	0.0%	0.1%	0.1%	0.0%
CyA + Siro/Evero + Steroids	2.6%	1.6%	0.6%	1.8%	0.9%	0.9%	0.7%	0.4%	0.2%	0.1%
Tac + Siro/Evero + Steroids	6.8%	11.0%	7.3%	4.9%	2.2%	2.5%	4.4%	1.3%	1.2%	1.0%
Other Regimen	6.7%	8.1%	5.9%	4.1%	1.8%	1.0%	2.0%	1.4%	1.0%	0.9%

Source: OPTN/SRTR Data as of October 1, 2010.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.